2022 Harvard Pulmonary And Critical Care Medicine

2022 Harvard Pulmonary And Critical Care Medicine

• Lung Transplantation: Referral, Patient Selection, Lung Allocation and COVID
• New Approaches to the Unexplained Chronic Cough
• Occupational and Environmental Lung Disease
• Cystic Fibrosis and Bronchiectasis: Understanding CFTR And New Treatment Options
• The Microbiome and Lung Disease
• Q & A Session with Speakers
• Pulmonary Pathology: Interstitial Lung Disease
• Diagnosis and Management of IPF: When, Why and How to Use the Newest Drugs
• Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD
• Hypersensitivity Pneumonitis: Pigeons, Farmers, and Hot Tubs, Oh My!
• Treatment Challenges of Pulmonary Sarcoidosis
• Palliative Care in Advanced Lung Disease
• Q & A Session with Speakers

• ARDS: State-of-the-Art Strategies to Protect the Lung
• Noninvasive Respiratory Support for Acute Respiratory Failure: Less May NOT Be Best
• Fluid Responsiveness
• Novel Ventilator Modes: The Hype and the Reality
• Sedation, Analgesia and Early Mobility: The State of the Art in 2022
• Point-of-Care Pulmonary Ultrasound in the Intensive Care Unit
• Q & A Session with Speakers
• Emerging Infectious Diseases
• COVID-19: Novel Therapeutics and New Developments
• Post-Acute Sequelae of COVID-19 (PASC): The Legacy of SARS-COV-2
• Breaking Research on PASC and Post-ICU Syndrome
• Approach to the Immunocompromised Critically Ill
• Vaping-Associated Acute Lung Injury
• Q & A Session with Speakers

• Common Neurologic Issues in the ICU
• Pathogenesis of Sepsis: Evolution of a New Paradigm
• Vasopressors in Septic Shock: Old Friends and New
• TTM and Neuroprognostication after Cardiac Arrest
• Prognosis and Uncertainty in the ICU
• Surgical Emergencies in the Medical ICU
• Q & A Session with Speakers
• Thrombotic Mechanisms and Antithrombotic Agents: How Do the New Oral Agents Fit In?
• Pulmonary Embolism: An Update
• Pulmonary Hypertension: Evaluation and Management
• Vasculitis and ANCA
• Exercise and Cardiopulmonary Disorders: Indications and Interpretation

• Pleural Disease: 2022 Updates
• Interventional Pulmonology in 2022
• Interventional Bronchoscopy in COPD: Valves, Coils and Beyond
• Q &A Session with Interventional Pulmonary Faculty
• Looking Deeper: Patterns and Insights from Chest Radiology
• A Strategic Approach to the Management of Pulmonary Nodules
• Treatment of Non-Small Cell Lung Cancer: Traditional Chemotherapy, Targeted Therapies, and Immunotherapies

COPD 2022

• Asthma: Ensuring Your Treatment Approaches Are Current with the State of the Art
• New Therapeutics in Lung Disease: The Age of Immunotherapy
• Community Acquired Pneumonia: The Newest Guidelines and State-of-the-Art Treatment Strategies
• Tuberculosis in 2022
• Nontuberculous Mycobacterial Disease: Navigating the Labyrinth
• Q & A Session

• Obstructive Sleep Apnea
• Central Sleep Apnea
• Sleep Diagnostics
• Noninvasive Ventilation for Neuromuscular Disorders and Alveolar Hypoventilation Syndromes